Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Medtech 360 | Market Analysis | Asia Pacific (Supplemental) | 2018

The Asia Pacific market for CRM devices will expand through 2026, driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology. The uptake of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs will also boost revenues.

This Medtech 360 Report provides key market metrics for the  CRM devices in Asia Pacific markets, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.

Related Medtech Insights Reports

Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…